• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共识推荐用于狗肾小球疾病的标准治疗。

Consensus recommendations for standard therapy of glomerular disease in dogs.

出版信息

J Vet Intern Med. 2013 Nov-Dec;27 Suppl 1:S27-43. doi: 10.1111/jvim.12230.

DOI:10.1111/jvim.12230
PMID:24635378
Abstract

Standard therapy forms the basic foundation for care of dogs with glomerular disease, as it is herein recommended for use in all affected animals regardless of causation of the disease. Consensus recommendations target the evaluation and management of proteinuria, inhibition of the renin-angiotensin-aldosterone system, modification in dietary intake with special consideration for those nutrients with renal effects, diagnosis and treatment of systemic hypertension, and evaluation and management of body fluid volume status in dogs with glomerular disease.

摘要

标准治疗构成了肾小球疾病犬护理的基本基础,因此建议所有受影响的动物使用,无论疾病的原因如何。共识建议针对蛋白尿的评估和管理、肾素-血管紧张素-醛固酮系统的抑制、饮食摄入的改变,特别考虑对肾脏有影响的营养素、全身性高血压的诊断和治疗,以及肾小球疾病犬体液量状态的评估和管理。

相似文献

1
Consensus recommendations for standard therapy of glomerular disease in dogs.共识推荐用于狗肾小球疾病的标准治疗。
J Vet Intern Med. 2013 Nov-Dec;27 Suppl 1:S27-43. doi: 10.1111/jvim.12230.
2
Canine glomerulonephritis: new thoughts on proteinuria and treatment.犬肾小球肾炎:蛋白尿与治疗的新思考
J Small Anim Pract. 2005 Oct;46(10):469-78. doi: 10.1111/j.1748-5827.2005.tb00275.x.
3
The renin-angiotensin-aldosterone system and its suppression.肾素-血管紧张素-醛固酮系统及其抑制作用。
J Vet Intern Med. 2019 Mar;33(2):363-382. doi: 10.1111/jvim.15454. Epub 2019 Feb 26.
4
Consensus recommendations for the diagnostic investigation of dogs with suspected glomerular disease.疑似肾小球疾病犬的诊断性检查共识建议。
J Vet Intern Med. 2013 Nov-Dec;27 Suppl 1:S19-26. doi: 10.1111/jvim.12223.
5
Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.肾素-血管紧张素-醛固酮系统抑制:血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂、盐皮质激素受体拮抗剂及直接肾素抑制剂治疗用途概述
Prim Care. 2014 Dec;41(4):765-78. doi: 10.1016/j.pop.2014.08.002. Epub 2014 Sep 29.
6
Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.抑制肾素-血管紧张素-醛固酮系统以实现脑肾保护。
Contrib Nephrol. 2013;179:7-14. doi: 10.1159/000346717. Epub 2013 May 3.
7
Consensus guidelines for immunosuppressive treatment of dogs with glomerular disease absent a pathologic diagnosis.无病理诊断肾小球疾病犬免疫抑制治疗的共识指南。
J Vet Intern Med. 2013 Nov-Dec;27 Suppl 1:S55-9. doi: 10.1111/jvim.12222.
8
Renin-angiotensin-aldosterone system inhibitors in heart failure.肾素-血管紧张素-醛固酮系统抑制剂在心力衰竭中的应用。
Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12.
9
How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?面对心肾综合征时,我们应如何调整推荐的肾素-血管紧张素-醛固酮系统抑制治疗?
Circ Heart Fail. 2014 May;7(3):536. doi: 10.1161/CIRCHEARTFAILURE.113.000843.
10
Consensus recommendations for immunosuppressive treatment of dogs with glomerular disease based on established pathology.基于既定病理学的犬肾小球疾病免疫抑制治疗共识建议。
J Vet Intern Med. 2013 Nov-Dec;27 Suppl 1:S44-54. doi: 10.1111/jvim.12228.

引用本文的文献

1
Chlorambucil Monotherapy in Dogs with Protein-Losing Nephropathy of Probable Immune Origin: A Preliminary Study.苯丁酸氮芥单药治疗可能为免疫起源的犬失蛋白性肾病:一项初步研究
Vet Sci. 2025 Jul 31;12(8):721. doi: 10.3390/vetsci12080721.
2
Prevalence of Proteinuria in Dogs With Immune-Mediated Disease.免疫介导性疾病犬蛋白尿的患病率
J Vet Intern Med. 2025 Jul-Aug;39(4):e70162. doi: 10.1111/jvim.70162.
3
Weekly Biological Variation of Urine Protein Creatinine Ratio and Urine Specific Gravity in Healthy Dogs.健康犬尿液蛋白肌酐比值和尿比重的每周生物学变异
J Vet Intern Med. 2025 Mar-Apr;39(2):e70052. doi: 10.1111/jvim.70052.
4
Coagulation status of immune-mediated polyarthritis in dogs.犬免疫介导性多关节炎的凝血状态
J Small Anim Pract. 2025 Jul;66(7):443-450. doi: 10.1111/jsap.13838. Epub 2025 Feb 25.
5
Analysis of survival among biopsy-determined categories of kidney disease in dogs.犬活检确诊的肾病类别中的生存情况分析。
J Vet Intern Med. 2025 Mar-Apr;39(2):e17301. doi: 10.1111/jvim.17301.
6
Serum symmetric dimethylarginine concentrations in enalapril- or telmisartan-treated dogs with proteinuric chronic kidney disease.依那普利或替米沙坦治疗的蛋白尿性慢性肾病犬的血清对称二甲基精氨酸浓度
Front Vet Sci. 2024 Dec 6;11:1471606. doi: 10.3389/fvets.2024.1471606. eCollection 2024.
7
Retrospective evaluation of risk factors for worsening renal function after angiotensin-converting enzyme inhibitor treatment in dogs.犬类接受血管紧张素转换酶抑制剂治疗后肾功能恶化危险因素的回顾性评估。
J Vet Intern Med. 2025 Jan-Feb;39(1):e17252. doi: 10.1111/jvim.17252. Epub 2024 Nov 20.
8
Characterization of the circulating markers of the renin-angiotensin-aldosterone system in telmisartan- or enalapril-treated dogs with proteinuric chronic kidney disease.替米沙坦或依那普利治疗的伴有蛋白尿的慢性肾病犬的肾素-血管紧张素-醛固酮系统循环标志物的特征。
J Vet Intern Med. 2024 Sep-Oct;38(5):2535-2547. doi: 10.1111/jvim.17186. Epub 2024 Aug 29.
9
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non-diabetic veterinary patients with cardiac and kidney diseases?钠葡萄糖协同转运蛋白2抑制剂:这些药物会使患有心脏和肾脏疾病的非糖尿病兽医患者受益吗?
J Vet Pharmacol Ther. 2025 Jan;48 Suppl 1(Suppl 1):1-18. doi: 10.1111/jvp.13472. Epub 2024 Jul 13.
10
Study of correlations between serum taurine, thyroid hormones and echocardiographic parameters of systolic function in clinically healthy Golden retrievers fed with commercial diet.临床健康的饲喂商业饮食的金毛寻回猎犬血清牛磺酸、甲状腺激素与超声心动图收缩功能参数相关性的研究。
PLoS One. 2024 May 16;19(5):e0297811. doi: 10.1371/journal.pone.0297811. eCollection 2024.